Procarbazine

Procarbazine is an approved oral anti-cancer drug used primarily as part of the MOPP regimen in the treatment of Hodgkin's disease. It inhibits DNA, RNA and protein synthesis. Side-effects can include bone marrow suppression, nausea and vomiting. It is taken in the form of capsules.

Procarbazine is manufactured by Cambridge Laboratories under the tradename Natulan.

Up a level
Back to contents
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.